CURIS INC

CRIS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 24 employees
377
SEC Filings
$0.5025
Close 2026-06-02
24
Employees

Business Summary

Curis Inc. (CRIS) is a biopharmaceutical company. The provided filing excerpt is limited to a subsidiary listing (Exhibit 21), identifying Curis Securities Corporation, a Massachusetts-organized subsidiary, as the sole listed entity doing business under its own name. Insufficient detail is available in this excerpt to fully describe Curis Inc.'s products, pipeline, or business operations beyond this subsidiary disclosure.

Latest Stock Quote

CRIS 2026-06-02 $0.5025 O:$0.5176 H:$0.536 L:$0.5001 Vol:0.1M VWAP:$0.521
origin leaf: b9ff856f2b0e04c831978723e78e03e790dfd0e9996f955c10f3d1408a168c04

Next Earnings

Q2 FY2026 — expected 2026-08-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-242025-12-310001108205-26-000043EDGAR95K words
2025-03-312024-12-310001108205-25-000031EDGAR
2024-02-082023-12-310001108205-24-000010EDGAR
2023-03-132022-12-310001108205-23-000023EDGAR
2022-02-242021-12-310001108205-22-000002EDGAR
2021-03-162020-12-310001108205-21-000003EDGAR
2020-03-192019-12-310001108205-20-000003EDGAR
2019-03-262018-12-310001108205-19-000004EDGAR
2018-03-082017-12-310001108205-18-000005EDGAR
2017-03-092016-12-310001108205-17-000006EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001108205-25-000107EDGAR23K words
2025-08-052025-06-300001108205-25-000080EDGAR
2025-05-062025-03-310001108205-25-000046EDGAR
2024-11-142024-09-300001108205-24-000072EDGAR
2024-08-012024-06-300001108205-24-000062EDGAR
2024-05-072024-03-310001108205-24-000033EDGAR
2023-11-022023-09-300001108205-23-000074EDGAR
2023-08-032023-06-300001108205-23-000060EDGAR
2023-05-042023-03-310001108205-23-000049EDGAR
2022-11-092022-09-300001108205-22-000023EDGAR
2022-08-042022-06-300001108205-22-000009EDGAR
2022-05-052022-03-310001108205-22-000005EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001108205-26-000030EDGAR3K words
2026-03-170001108205-26-000016EDGAR
2026-02-090001108205-26-000006EDGAR
2026-01-080001108205-26-000002EDGAR
2025-11-060001108205-25-000105EDGAR
2025-10-240001108205-25-000098EDGAR
2025-08-220001108205-25-000093EDGAR
2025-08-080001108205-25-000087EDGAR
2025-08-050001108205-25-000079EDGAR
2025-07-020001108205-25-000072EDGAR

377 total filings indexed. 345 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001108205
TickerCRIS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.curis.com
Listed2000-08-01

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e926fcde459b13e78b61e53a5d5dec5920c092318624f04e67e0bdac93a5fdc7
parent: 61493d3f19ec5d61ab0ca3e5a1e9e71c6c8028ef8a27c0c255cf7edf92d33c5f
content hash: f908d5cc40e952e134b8cc7138068a72dec1b22dfc599b5edc8ae8a2207bef8b
signed: 2026-06-03T12:00:44.720Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf